179 related articles for article (PubMed ID: 18794908)
1. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
[TBL] [Abstract][Full Text] [Related]
2. Methodological quality of pharmacogenetic studies: issues of concern.
Jorgensen AL; Williamson PR
Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
[TBL] [Abstract][Full Text] [Related]
3. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group.
Anderson DC; Gomez-Mancilla B; Spear BB; Barnes DM; Cheeseman K; Shaw PM; Friedman J; McCarthy A; Brazell C; Ray SC; McHale D; Hashimoto L; Sandbrink R; Watson ML; Salerno RA; Cohen N; Lister CE;
Pharmacogenomics J; 2002; 2(5):284-92. PubMed ID: 12439734
[No Abstract] [Full Text] [Related]
4. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
Serretti A; Kato M; Kennedy JL
Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics in drug discovery and development: a translational perspective.
Roses AD
Nat Rev Drug Discov; 2008 Oct; 7(10):807-17. PubMed ID: 18806753
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: from bench to byte.
Swen JJ; Wilting I; de Goede AL; Grandia L; Mulder H; Touw DJ; de Boer A; Conemans JM; Egberts TC; Klungel OH; Koopmans R; van der Weide J; Wilffert B; Guchelaar HJ; Deneer VH
Clin Pharmacol Ther; 2008 May; 83(5):781-7. PubMed ID: 18253145
[TBL] [Abstract][Full Text] [Related]
8. Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop.
Salerno RA; Lesko LJ
Pharmacogenomics J; 2006; 6(2):78-81. PubMed ID: 16402087
[No Abstract] [Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop.
Lesko LJ; Salerno RA; Spear BB; Anderson DC; Anderson T; Brazell C; Collins J; Dorner A; Essayan D; Gomez-Mancilla B; Hackett J; Huang SM; Ide S; Killinger J; Leighton J; Mansfield E; Meyer R; Ryan SG; Schmith V; Shaw P; Sistare F; Watson M; Worobec A
J Clin Pharmacol; 2003 Apr; 43(4):342-58. PubMed ID: 12723455
[TBL] [Abstract][Full Text] [Related]
10. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
Wang SJ
Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of osteoporosis: future perspectives.
Marini F; Brandi ML
Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
[TBL] [Abstract][Full Text] [Related]
12. The drug diagnostic co-development concept paper: commentary from the 3rd FDA-DIA-PWG-PhRMA-BIO Pharmacogenomics Workshop.
Hinman LM; Huang SM; Hackett J; Koch WH; Love PY; Pennello G; Torres-Cabassa A; Webster C
Pharmacogenomics J; 2006; 6(6):375-80. PubMed ID: 16652120
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetic/regulatory aspects seen from the viewpoint of the industry].
Hansen L; Andersen D
Ugeskr Laeger; 2005 May; 167(20):2160-4. PubMed ID: 15987073
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics in psychiatry: clinical issues to be considered.
Licinio J; Wong ML
Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
[No Abstract] [Full Text] [Related]
16. The ethical implications of stratifying by race in pharmacogenomics.
Lee SS
Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
[TBL] [Abstract][Full Text] [Related]
17. Applications of microarrays and biochips in pharmacogenomics.
Hardiman G
Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics and therapeutic strategies for dementia.
Cacabelos R
Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
[TBL] [Abstract][Full Text] [Related]
19. Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary.
Wang SJ; Cohen N; Katz DA; Ruano G; Shaw PM; Spear B
Pharmacogenomics J; 2006; 6(2):82-8. PubMed ID: 16402078
[No Abstract] [Full Text] [Related]
20. Preparing for the revolution--pharmacogenomics and the clinical lab.
Mehr IJ
Pharmacogenomics; 2000 Feb; 1(1):1-4. PubMed ID: 11258591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
